Acquisition Criteria Remain Conservative For Large Cardiovascular Firms
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific, Guidant and St. Jude Medical business development chiefs are reluctant to consider technologies outside their firms' core strengths when weighing potential acquisitions